{{Rsnum
|rsid=4766578
|Gene=ATXN2
|Chromosome=12
|position=111466567
|Orientation=plus
|GMAF=0.2259
|Gene_s=ATXN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 31.7 | 52.4 | 15.9
| HCB | 0.0 | 0.0 | 0.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22561518
|Trait=None
|Title=Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
|RiskAllele=T
|Pval=4E-18
|OR=1.3200
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}